Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1987-2-19
|
| pubmed:language |
ita
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0017-0275
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
67
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
145-9
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:3792721-Anemia, Hypochromic,
pubmed-meshheading:3792721-Ferric Compounds,
pubmed-meshheading:3792721-Ferritins,
pubmed-meshheading:3792721-Humans,
pubmed-meshheading:3792721-Intestinal Absorption,
pubmed-meshheading:3792721-Male,
pubmed-meshheading:3792721-Quaternary Ammonium Compounds
|
| pubmed:year |
1986
|
| pubmed:articleTitle |
[Ferritin and ammonium-ferric citrate. Considerations on absorption modality and therapeutic effectiveness].
|
| pubmed:publicationType |
Journal Article,
English Abstract
|